by CheckRare Staff | Aug 7, 2023
Philip L. Pearl, MD, Director, Epilepsy and Clinical Neurophysiology, Boston Children’s Hospital, William G. Lennox Chair and Professor of Neurology, Harvard Medical School, Boston, MA discusses aromatic L-amino acid decarboxylase (AADC) deficiency and the recently...
by CheckRare Staff | Aug 4, 2023
Michael Thorner, MB, Vice President of Endocrine Science at Lumos Pharma discusses the latest research on LUM 201 (ibutamoren) to treat idiopathic pediatric growth hormone deficiency. Growth hormone deficiency is a rare endocrine disorder....
by CheckRare Staff | Aug 3, 2023
Vera Bril, MD, Professor of Medicine at the University of Toronto discusses the recent approval rozanolixizumab to treat myasthenia gravis. Myasthenia gravis is a chronic autoimmune neuromuscular disease characterized by weakness of the skeletal...
by CheckRare Staff | Aug 2, 2023
Vera Bril, MD, Professor of Medicine at the University of Toronto discusses rozanolixizumab’s treatment mechanism to treat myasthenia gravis. Myasthenia gravis is a chronic autoimmune neuromuscular disease characterized by weakness of the skeletal...
by CheckRare Staff | Aug 1, 2023
Scott Schobel, MD, Chief Medical Officer at Vico Therapeutics, discusses current treatment options for Huntington’s disease and spinocerebellar ataxia (SCA1 and SCA3). Huntington’s disease is a rare neurodegenerative disorder characterized by...
